The Miami Stem Cell Treatment Center Announces Adult Stem Cell Public Seminars in Baco Raton and Fort Lauderdale …

Fort Lauderdale and Boca Raton, Florida (PRWEB) December 02, 2014

The Miami Stem Cell Treatment Center announces a series of free public seminars on the use of adult stem cells for various chronic, degenerative and inflammatory conditions. They will be provided by Dr. Thomas A. Gionis, Surgeon-in-Chief.

The seminars will be held on Sunday, December 7, 2014, at 1:00pm and 3:00pm at the Miami Stem Cell Treatment Center, 1515 N. Federal Highway, Suite 105, Boca Raton, FL 33432 and Thursday, December 11, 2014 at 2:00 pm at the Thasos Greek Taverna, 3330 E. Oakland Park Blvd, Ft. Lauderdale, FL 33308. Please RSVP at (561) 331-2999.

The Miami Stem Cell Treatment Center abides by investigational protocols using adult adipose derived stem cells (ADSCs) which can be deployed to improve patients quality of life for a number of chronic, degenerative and inflammatory conditions and diseases. ADSCs are taken from the patients own adipose (fat) tissue (found within a cellular mixture called stromal vascular fraction (SVF)). ADSCs are exceptionally abundant in adipose tissue. The adipose tissue is obtained from the patient during a 15 minute mini-liposuction performed under local anesthesia in the doctors office. SVF is a protein-rich solution containing mononuclear cell lines (predominantly adult autologous mesenchymal stem cells), macrophage cells, endothelial cells, red blood cells, and important Growth Factors that facilitate the stem cell process and promote their activity. ADSCs are the body's natural healing cells - they are recruited by chemical signals emitted by damaged tissues to repair and regenerate the bodys injured cells. The Miami Stem Cell Treatment Center only uses Adult Autologous Stem Cells from a persons own fat No embryonic stem cells are used. Current areas of study include: Emphysema, COPD, Asthma, Heart Failure, Parkinsons Disease, Stroke, Multiple Sclerosis, Lupus, Rheumatoid Arthritis, Crohns Disease, and degenerative orthopedic joint conditions. For more information, or if someone thinks they may be a candidate for one of the adult stem cell protocols offered by the Miami Stem Cell Treatment Center, they may contact Dr. Gionis directly at (561) 331-2999, or see a complete list of the Centers study areas at: http://www.MiamiStemCellsUSA.com.

About the Miami Stem Cell Treatment Center: The Miami Stem Cell Treatment Center is an affiliate of the Cell Surgical Network (CSN); they are located in Baco Raton, Orlando, and Miami, Florida. We provide care for people suffering from diseases that may be alleviated by access to adult stem cell based regenerative treatment. We utilize a fat transfer surgical technology to isolate and implant the patients own stem cells from a small quantity of fat harvested by a mini-liposuction on the same day. The investigational protocols utilized by the Miami Stem Cell Treatment Center have been reviewed and approved by an IRB (Institutional Review Board) which is registered with the U.S. Department of Health, Office of Human Research Protection; and the study is registered with Clinicaltrials.gov, a service of the U.S. National Institutes of Health (NIH). For more information visit our website: http://www.MiamiStemCellsUSA.com.

Visit link:
The Miami Stem Cell Treatment Center Announces Adult Stem Cell Public Seminars in Baco Raton and Fort Lauderdale ...

UF researchers recruiting local pets for arthritis study

ORLANDO, Fla. -

If you think your dog is suffering from arthritis, researchers at the University of Floridas Health Science Center want you.

[WEB EXTRA: See if your pet meets study criteria | More info on stem cell process ]

Well, actually your pet.

Your dog may be eligible for a blind study being conducted by the University of Floridas College of Veterinary Medicine.

UF veterinarians are looking for 30 dogs, ages 2 to 10 years old, to participate in the next phase of a stem cell therapy project.

The dogs must be healthy, 10 to 120 pounds, and should have been diagnosed with elbow arthritis or dysplasia by their local vet.

Doctors are injecting stem cells directly into the elbows (front leg joints) of the animals to determine if the treatment will decrease the inflammation and pain associated with elbow dysplasia.

Dr. Stanley Kim, a specialist in small animal surgery, says some pets are given a placebo and not even the owner will know if saline or stem cells have been injected into the pets joints until the 6 month study is completed.

The dogs are evaluated at one month, three months and then again at six months but no dog will be left without the stem cell therapy.

Read more:
UF researchers recruiting local pets for arthritis study

Advances reshape stem cell research

A decade ago, a dream team of researchers from Pittsburgh to South Korea claimed a medical invention that promised to reshape a culture war.

The scientists said they custom-designed stem cells from cloned human embryos. The scientific breakthrough was celebrated around the globe.

Then the bottom fell out.

A scandal erupted over fabricated data, and University of Pittsburgh biologist Gerald Schatten was forced to pull back the findings. Critics cast the 2004 discovery as a farce, a high-profile fraud that forced the journal Science into a rare retraction in January 2006.

Eight years later, the push to use stem cells as a medical treatment continues, but scholars balk at the suggestion that anyone is trying to make genetically identical individuals.

We're not here to clone human beings, for gosh sakes, said John Gearhart, a stem cell researcher and University of Pennsylvania professor in regenerative medicine. Instead, he said, scholars are working to manipulate stem cells to produce heart cells for cardiac patients, brain cells for neurological patients and other custom transplants that could match a person's genetic makeup.

Schatten's work continues at the Magee-Womens Research Institute at Pitt, where university officials cleared him of scientific misconduct, and he remains a vice chairman for research development. He focuses on educating and training physician-scientists and other scientists, a school spokeswoman wrote in a statement. She said Schatten was traveling and was unable to speak with the Tribune-Review.

Researchers have turned the onetime myth of developing stem cells into reality.

At the Oregon Health and Science University, researchers succeeded by blending unfertilized human eggs with body tissue to mold stem cells. Scholars say the cells could let doctors grow customized organs for transplants and other therapies.

The approach engineered by biologist Shoukhrat Mitalipov's research team last year in Portland is among two that scientists are using to forge laboratory-made stem cells the so-called master cells that can transform into other body parts without relying on donated human embryos. Federal law tightly controls the use of taxpayer money for embryonic research.

Link:
Advances reshape stem cell research

The Miami Stem Cell Treatment Center Announces Adult Stem Cell Public Seminars in The Villages, Florida

The Villages, Florida (PRWEB) November 26, 2014

The Miami Stem Cell Treatment Center announces a series of free public seminars on the use of adult stem cells for various chronic, degenerative and inflammatory conditions. They will be provided by Dr. Thomas A. Gionis, Surgeon-in-Chief and Dr. Nia Smyrniotis, Medical Director.

The seminars will be held on Monday, December 8, 2014, at 1:00pm, 3:00pm and 5:00pm at TownPlace Suites The Villages Marriott, 1141 Alonzo Ave., The Villages, FL 32159. Please RSVP at (561) 331-2999.

The Miami Stem Cell Treatment Center abides by investigational protocols using adult adipose derived stem cells (ADSCs) which can be deployed to improve patients quality of life for a number of chronic, degenerative and inflammatory conditions and diseases. ADSCs are taken from the patients own adipose (fat) tissue (found within a cellular mixture called stromal vascular fraction (SVF)). ADSCs are exceptionally abundant in adipose tissue. The adipose tissue is obtained from the patient during a 15 minute mini-liposuction performed under local anesthesia in the doctors office. SVF is a protein-rich solution containing mononuclear cell lines (predominantly adult autologous mesenchymal stem cells), macrophage cells, endothelial cells, red blood cells, and important Growth Factors that facilitate the stem cell process and promote their activity.

ADSCs are the body's natural healing cells - they are recruited by chemical signals emitted by damaged tissues to repair and regenerate the bodys injured cells. The Miami Stem Cell Treatment Center only uses Adult Autologous Stem Cells from a persons own fat No embryonic stem cells are used. Current areas of study include: Emphysema, COPD, Asthma, Heart Failure, Parkinsons Disease, Stroke, Multiple Sclerosis, Lupus, Rheumatoid Arthritis, Crohns Disease, and degenerative orthopedic joint conditions. For more information, or if someone thinks they may be a candidate for one of the adult stem cell protocols offered by the Miami Stem Cell Treatment Center, they may contact Dr. Smyrniotis or Dr. Gionis directly at (561) 331-2999, or see a complete list of the Centers study areas at: http://www.MiamiStemCellsUSA.com.

About the Miami Stem Cell Treatment Center: The Miami Stem Cell Treatment Center is an affiliate of the Cell Surgical Network (CSN); they are located in Baco Raton, Orlando, and Miami, Florida. We provide care for people suffering from diseases that may be alleviated by access to adult stem cell based regenerative treatment. We utilize a fat transfer surgical technology to isolate and implant the patients own stem cells from a small quantity of fat harvested by a mini-liposuction on the same day. The investigational protocols utilized by the Miami Stem Cell Treatment Center have been reviewed and approved by an IRB (Institutional Review Board) which is registered with the U.S. Department of Health, Office of Human Research Protection; and the study is registered with Clinicaltrials.gov, a service of the U.S. National Institutes of Health (NIH). For more information visit our website: http://www.MiamiStemCellsUSA.com.

Read the original post:
The Miami Stem Cell Treatment Center Announces Adult Stem Cell Public Seminars in The Villages, Florida

Devon Still hurried to be by daughter Leahs side as she got stem-cell treatment

Bengals defensive lineman Devon Still is a busy man these days, practicing and playing football in Cincinnati, then flying over to Philadelphia, where his daughter Leah is a cancer patient at Childrens Hospital.Of course, Still would be the first to tell that what hes going through is nothing compared to his daughters ordeal.

Leah was scheduled to undergo stem-cell treatment Tuesday, in order to alleviate some of the internal damage caused by chemotherapy and radiation. There was no way Still was going to miss out on being by thefour-year-olds side.

Mission accomplished, Still had to hurry back to work.

Support for Leah and other kids stricken with pediatric cancer continues to pour in. On Saturday, members of the AHLs Syracuse Crunchdonned Stills No. 75 Bengals jersey as they competed in theFrozen Dome Classic at the Carrier Dome. According to cincinnati.com, the jerseys were then signed and will be auctioned off, with the proceeds going to Ronald McDonald House.

This former editor and part-time writer at The Post is now happy to prove that if you combine 'blowhard' and 'blaggard,' you get 'blogger.' He previously had used 'Desmond Bieler' as his byline, but feels that shortening the first name to 'Des' nicely conveys his ever-decreasing gravitas. He also covers Fantasy Football.

View original post here:
Devon Still hurried to be by daughter Leahs side as she got stem-cell treatment

Great Ormond Street stem cell freezing problem may have led to girls death

Technical failures at Great Ormond Street hospital may have contributed to Sophie Ryan-Palmer's death. Photograph: Steve Parsons/PA Archive

A 12-year-old cancer patient may have died because of problems in a stem cell freezing process used by Great Ormond Street hospital.

Technical failures at the childrens NHS trust could have contributed to the death of Sophie Ryan-Palmer, from Sunbury in Surrey, St Pancras coroners court has been told.

In a narrative verdict, the coroner, Mary Hassell, said it was unclear what effect the treatment had but she ruled that the deaths of three other children at the hospital were not connected to difficulties with the medical procedure.

The other three children were 13-month-old Ryan Loughran, from Bournemouth, who died in July, four-year-old Katie Joyce, from Hertfordshire, who died in October, and five-year-old Muhanna al-Hayany, who had come from Kuwait to receive the treatment and died in August this year.

Responding to the findings, a spokesperson for Great Ormond Street said: This has been an immensely distressing process for all of the families involved. These four young patients were extremely poorly children with complex conditions, and it is frustrating for everyone concerned, especially their families, for it still to be unclear exactly what caused the freezing problem and to what extent this might have contributed to one patients eventual outcome.

As soon as we identified a potential problem with our stem cell freezing process in 2013, we stopped freezing cells on site and used alternative facilities in other London hospitals while an investigation was undertaken.

We had tested all of these cells prior to transplant, following UK national standards of testing, and the results of these tests had indicated the cells were alive and viable. Therefore at this stage there was no indication of any problem, and it was only after a period of time had elapsed that the pattern of delayed engraftment began to emerge among a group of patients.

The hospital has reintroduced freezing of cells using an alternative method, which is in use in other hospitals across the country. Great Ormond Streets previous freezing method is in use at other hospitals.

The trusts statement added: We welcome the coroners recommendation to create a more standardised approach to the way the medical community shares knowledge nationally about autologous stem cell transplants in children with cancer, to raise awareness of any issues uncovered and ensure a similar problem does not occur again. Autologous transplants are those where the donor is also the recipient.

See the article here:
Great Ormond Street stem cell freezing problem may have led to girls death

Leah Still to undergo stem cell therapy

CINCINNATI -- The daughter of a Cincinnati Bengal who has already been through so much has another big day ahead of her.

Leah Still -- Devon Stills daughter -- will undergo a stem cell transplant procedure on Tuesday. The stem cell treatment is an effort to regenerate her bone marrow and stem cells.

Still flew to Philadelphia Monday to be with Leah. They went shopping at a mall.

The smile you have after shutting down the mall, literally. This girl had security and the... http://t.co/HHWtLhf4pf pic.twitter.com/QFRMJsdlCX

Still tweeted another photo Tuesday while they waited for her treatment to begin.

Selfies in the hospital to pass time by as we wait for the stem cells http://t.co/q6JZOIyi9q pic.twitter.com/ogB0J0Gitg

Leah was diagnosed with stage 4 neuroblastoma in June. She had surgery to remove a tumor from her abdomen in September, followed by chemotherapy to try to remove the cancer from her bone marrow.

She has already been treated with a round of chemotherapy and radiation.

Devon Still said the family hopes that will be her only round of chemo and radiation but that it depends on how her results come back. He said it will take four to six weeks to determine if more treatments are necessary.

Follow Devon Still's updates on Twitter at @Dev_Still71

Go here to read the rest:
Leah Still to undergo stem cell therapy

New Stem Cell Treatment Found To Cure 'Bubble Baby' Disease

Chuck Bednar for redOrbit.com Your Universe Online

A new stem cell gene therapy developed by researchers at UCLA is set to begin clinical trials early next year after the technique reportedly cured 18 children who were born without working immune systems due to a condition known as ADA-deficient Severe Combined Immunodeficiency (SCID) or Bubble Baby disease.

The treatment was developed by Dr. Donald Kohn, a member of the UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, and his colleagues, and according to the university, it is able to identify and correct faulty genes by using the DNA of the youngsters born with this life-threatening condition.

Left untreated, ADA-deficient SCID is often fatal within the first year of a childs life, reports Peter M. Bracke for UCLA. However, after more than three decades of research, Dr. Kohns team managed to develop a gene therapy that can safely restore the immune systems of children with the disease by using their own cells and with no noticeable side effects.

All of the children with SCID that I have treated in these stem cell clinical trials would have died in a year or less without this gene therapy, instead they are all thriving with fully functioning immune systems, Dr. Kohn, who is also a professor of pediatrics and of microbiology, immunology and molecular genetics, said in a recent statement.

Children born with SCID have to be isolated in a controlled environment for their own safety, because without an immune system, they are extremely vulnerable to illnesses and infections that could be deadly. While there are other treatments for ADA-deficient SCID, Dr. Kohn noted that they are not always optimal or feasible for many children. The new technique, however, provides them with a cure, and the chance to live a full healthy life.

SCID is an inherited immunodeficiency that is typically diagnosed about six months after birth, the researchers said, and children with the condition are so vulnerable to infectious diseases that even the common cold could prove fatal to them. This particular form of the condition causes cells to not create ADA, an enzyme essential for the production of the white blood cells which are a vital component of a healthy, normally-functioning immune system.

Approximately 15 percent of all SCID patients are ADA-deficient, according to the university, and these youngsters are typically treated by being injected twice per week with the required enzyme. This is a process that must continue throughout a patients entire life, and even then it doesnt always work to bring their immune systems to optimal levels. Alternately, they could undergo bone marrow transplants from matched siblings, but those matches are rare and the transplanted cells themselves are often rejected by the childs body.

Dr. Kohn and his colleagues tested two therapy regimens on 18 ADA-deficient SCID over the course of two multi-year clinical trials starting in 2009. During the trials, the blood stem cells of the patients were removed from their bone marrow and genetically modified in order to correct the defect. All 18 of the patients were cured.

The technique used a virus delivery system first developed in Dr. Kohns laboratory in the 1990s a technique which inserts the corrected gene that produces the ADA into the blood forming stem cells in the bone marrow. The genetically corrected blood-forming stem cells will then produce the T-cells required to combat infections.

Visit link:
New Stem Cell Treatment Found To Cure 'Bubble Baby' Disease

Stem cell trial to begin for children suffering from cerebral palsy

Nov. 23, 2014, 3:05 p.m.

It is hoped that a trial due to start next year, and involving about 20 Australian children with cerebral palsy, will show the benefits of using stem cells from their own umbilical cord blood to treat the condition.

About 20 Australian children with cerebral palsy will be infused with their own umbilical cord blood in a trial due to start next year, as physicians warn families against travelling overseas for experimental stem cell treatments.

The long-awaited Australian trial will provide some of the world's first evidence about the safety and effectiveness of using stem cells from umbilical cord blood to repair brain injury that leads to cerebral palsy.

Researchers are waiting on ethics approval for the trial which will provide treatment to families who have chosen to store their child's cord blood at private banks.

In some cases, children with cerebral palsy will be able to receive a sibling's cord blood if this is available.

Cerebral Palsy Alliance head of research Iona Novak said the study, led by the Murdoch Childrens Research Institute, will recruit children from around Australia who have access to privately banked cord blood.

Children aged one to 10 will receive infusions at private blood banks in Melbourne, Sydney and Brisbane, and will be assessed before and after the treatment to check for improvements.

Researchers will be unable to access cord blood from a public bank, which collects blood to treat blood disorders such as leukaemia and cannot be used for untested new therapies.

Associate Professor Novak said the trial was an important first step towards establishing whether stem cells could help repair the brain injury that leads to cerebral palsy, a series of disabilities associated with movement and posture.

Read more:
Stem cell trial to begin for children suffering from cerebral palsy

MS treatment first for Inverness mum

Published: 22/11/2014 08:00 - Updated: 21/11/2014 17:04

Written byVal Sweeney

Lucy Clarke hopes pioneering MS treatment will enable her enjoy walks in the park with son, Theo (4) and husband, Dan Jenkins.

A mother with multiple sclerosis is hoping to become the first Scottish patient to undergo cutting edge stem-cell treatment in a Russian clinic.

Lucy Clarke, of Inverness, hopes to raise 40,000 via crowd-funding for the procedure which involves transplanting her own stem cells into her body.

The 38-year-old was first diagnosed with MS, a disease of the central nervous system, nine years ago.

With her condition now worsening, she has opted for treatment unavailable in the UK in a bid to halt the diseases progress and to enjoy family activities such as walking in the park.

In April, the acupuncturist will travel to Moscows Pirogov Center where just 25 patients a year receive Hematopoietic Stem Cell Transplantation (HSCT).

To help fund her one-month stay and post-treatment rehabilitation, her family have set up a campaign website. They are selling Lucys Light candles and her mother is also planning a fundraising skydive to coincide with her 70th birthday.

Any surplus money will be used to set up a charity to support others with MS.

Excerpt from:
MS treatment first for Inverness mum